Careium AB (publ)
STO:CARE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Careium AB (publ)
STO:CARE
|
SE |
|
D
|
Defence Therapeutics Inc
CNSX:DTC
|
CA |
|
A
|
Amplifon SpA
LSE:0N61
|
IT |
Cash Flow Statement
Cash Flow Statement
Careium AB (publ)
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||
| Net Income |
(21)
|
(14)
|
(32)
|
(16)
|
16
|
17
|
56
|
59
|
71
|
78
|
74
|
84
|
82
|
70
|
68
|
49
|
|
| Depreciation & Amortization |
62
|
67
|
86
|
75
|
74
|
74
|
78
|
79
|
76
|
74
|
68
|
67
|
68
|
68
|
68
|
70
|
|
| Other Non-Cash Items |
(20)
|
(17)
|
(25)
|
(40)
|
(6)
|
(14)
|
(9)
|
(5)
|
(6)
|
(1)
|
(3)
|
(10)
|
(23)
|
(26)
|
(25)
|
(24)
|
|
| Cash Interest Paid |
0
|
0
|
0
|
9
|
0
|
0
|
0
|
16
|
0
|
0
|
0
|
13
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(5)
|
4
|
(10)
|
(40)
|
(89)
|
(75)
|
(100)
|
(21)
|
(39)
|
(53)
|
(28)
|
(48)
|
(43)
|
(23)
|
(2)
|
49
|
|
| Cash from Operating Activities |
17
N/A
|
40
+141%
|
19
-52%
|
(21)
N/A
|
(5)
+75%
|
3
N/A
|
25
+772%
|
112
+342%
|
103
-8%
|
98
-4%
|
112
+14%
|
93
-17%
|
83
-10%
|
89
+7%
|
109
+22%
|
143
+31%
|
|
| Investing Cash Flow | |||||||||||||||||
| Capital Expenditures |
(61)
|
(60)
|
(74)
|
(66)
|
(58)
|
(55)
|
(53)
|
(50)
|
(53)
|
(55)
|
(56)
|
(56)
|
(67)
|
(73)
|
(82)
|
(92)
|
|
| Other Items |
(113)
|
(71)
|
(71)
|
(3)
|
(3)
|
(3)
|
(3)
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
(10)
|
|
| Cash from Investing Activities |
(173)
N/A
|
(131)
+24%
|
(145)
-10%
|
(69)
+52%
|
(61)
+12%
|
(57)
+5%
|
(55)
+3%
|
(50)
+10%
|
(53)
-5%
|
(55)
-5%
|
(56)
0%
|
(56)
-1%
|
(67)
-20%
|
(73)
-8%
|
(82)
-12%
|
(102)
-25%
|
|
| Financing Cash Flow | |||||||||||||||||
| Net Issuance of Debt |
154
|
55
|
49
|
(15)
|
5
|
20
|
19
|
(70)
|
(59)
|
(60)
|
(63)
|
(40)
|
(22)
|
(15)
|
(24)
|
(14)
|
|
| Other |
99
|
76
|
76
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
|
| Cash from Financing Activities |
253
N/A
|
131
-48%
|
125
-5%
|
(15)
N/A
|
5
N/A
|
20
+270%
|
19
-2%
|
(70)
N/A
|
(59)
+15%
|
(60)
-1%
|
(63)
-5%
|
(40)
+37%
|
(22)
+44%
|
(15)
+32%
|
(24)
-61%
|
(14)
+43%
|
|
| Change in Cash | |||||||||||||||||
| Effect of Foreign Exchange Rates |
1
|
2
|
2
|
2
|
2
|
5
|
3
|
(1)
|
2
|
(2)
|
(1)
|
3
|
(3)
|
(2)
|
(4)
|
(4)
|
|
| Net Change in Cash |
97
N/A
|
42
-57%
|
2
-95%
|
(103)
N/A
|
(59)
+42%
|
(30)
+49%
|
(8)
+75%
|
(8)
-11%
|
(7)
+17%
|
(19)
-171%
|
(7)
+63%
|
1
N/A
|
(9)
N/A
|
(1)
+93%
|
(1)
-33%
|
23
N/A
|
|
| Free Cash Flow | |||||||||||||||||
| Free Cash Flow |
(44)
N/A
|
(20)
+54%
|
(54)
-171%
|
(87)
-60%
|
(63)
+27%
|
(52)
+18%
|
(27)
+47%
|
62
N/A
|
50
-19%
|
43
-14%
|
56
+30%
|
37
-34%
|
16
-57%
|
16
+3%
|
27
+66%
|
51
+88%
|
|